Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC look forward to the opportunity to share clinical information on our products.
For additional information regarding Jardiance® (empagliflozin) tablets, visit us at www.jardiancehcp.com. For all other inquiries, contact us at www.bidruginforequest.com
Please see JARDIANCE Prescribing Information, including Medication Guide.
Contact:
Jessica Chadwell, RN, BSN
E-mail - jessica.chadwell@boehringer-ingelheim.com
The Value of Jardiance within Health Systems »
